LDLRAD3 and pancreatic neoplasm: Circ-LDLRAD3 is upregulated in both pancreatic cancer tissues and plasma obtained from patients with pancreatic cancer, and the AUC value, sensitivity and specificity when combined with CA19–9 was 0.87, 0.8033 and 0.9355, respectively [70].